INOVIO PHARMACEUTICALS, INC. Short-term Investments
INOVIO PHARMACEUTICALS, INC. (INO) had Short-term Investments of $5.15 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-12
- 2026-06-30: Short-term Investments $5.15M.
- 2026-03-31: Short-term Investments $11.41M.
- 2025-12-31: Short-term Investments $14.24M.
- 2025-09-30: Short-term Investments $14.24M.
| Period end | Short-term Investments |
|---|---|
| 2026-06-30 | $5.15M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $11.41M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $14.24M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $14.24M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $23.20M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $28.45M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $28.30M 10-K · filed 2026-03-12 |
| 2024-09-30 | $63.12M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $76.03M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $86.01M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $130.98M 10-K · filed 2025-03-18 |
| 2023-09-30 | $148.67M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $142.21M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $195.51M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $206.67M 10-K · filed 2024-03-06 |
| 2022-09-30 | $259.89M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $307.02M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $301.38M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $330.17M 10-K · filed 2023-03-01 |
| 2021-09-30 | $327.00M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $384.75M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $434.97M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $160.91M 10-K · filed 2022-03-01 |
| 2020-09-30 | $158.54M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $156.23M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $111.55M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $67.34M 10-K · filed 2021-03-01 |
| 2019-09-30 | $77.95M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $86.24M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $107.22M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $57.54M 10-K · filed 2020-03-12 |
| 2018-09-30 | $66.10M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $80.51M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $75.26M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $103.64M 10-K · filed 2019-03-12 |
| 2017-09-30 | $118.61M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $68.14M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $66.76M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $85.63M 10-K · filed 2018-03-14 |
| 2016-09-30 | $96.44M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $106.08M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $105.16M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $105.36M 10-K · filed 2017-03-15 |
| 2015-09-30 | $85.31M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $84.30M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $54.87M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $53.08M 10-K · filed 2016-03-14 |
| 2014-09-30 | $30.26M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $20.32M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $18.01M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $18.91M 10-K · filed 2015-03-16 |
| 2013-09-30 | $13.10M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $13.11M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $7.98M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $8.03M 10-K · filed 2014-03-17 |
| 2012-09-30 | $10.55M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $13.49M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $13.73M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $12.86M 10-K · filed 2013-03-18 |
| 2011-09-30 | $5.76M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $5.76M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $1.85M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |